Therakos therapeutic platforms, including the latest generation THERAKOS® CELLEX®Photopheresis System, are the world’s only approved, fully-integrated systems for administering autologous immune cell therapy through extracorporeal photopheresis (ECP). CTL partners with Therakos to implement AX Supply Chain Management for Therakos systems are used by academic medical centers, hospitals, and treatment centers in more than 30 countries and have already delivered over one million treatments globally.